Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci

20 Oct 2015

Abstract excerpt

Group A streptococcal (Streptococcus pyogenes) diseases remain a major public health problem in developing countries as well as in the indigenous populations of developed countries. In view of the large number of Group A streptococcal infections and the potential for sequelae such as rheumatic heart disease, control strategies including the development of an anti-streptococcal vaccine that is able to prevent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Neonatal and Maternal Infections
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26485214
DOI: 10.1586/14760584.2015.1081817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococciPMID 26485214Read ↗

Molecular biology of Group A Streptococcus and its implications in vaccine strategies.Semantic proximity Read ↗

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based VaccineSemantic proximity Read ↗

Update on the development of Group A Streptococcus vaccinesSemantic proximity Read ↗

Contribution of cryptic epitopes in designing a group A streptococcal vaccine.Semantic proximity Read ↗

The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification markerSemantic proximity Read ↗

Unveiling the Group A Streptococcus Vaccine-Based L-Rhamnose from Backbone of Group A Carbohydrate: Current Insight Against Acute Rheumatic Fever to Reduce the Global Burden of Rheumatic Heart DiseaseSemantic proximity Read ↗

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Semantic proximity Read ↗

Anti-Group A Streptococcal Vaccine EpitopeSemantic proximity Read ↗

Streptococcus pyogenes strains in Sao Paulo, Brazil: molecular characterization as a basis for StreptInCor coverage capacity analysis.Semantic proximity Read ↗

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine DevelopmentSemantic proximity Read ↗

Structural vaccinology-based design of multi-epitopes vaccine against Streptococcus gordonii and validation using molecular modeling and immune simulation approachesSemantic proximity Read ↗

Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.